|
|
|
|
|
|
|
|
|
08.05.26 - 12:36
|
Cresco Labs Reports First Quarter 2026 Financial Results, Advances Multiple Growth Initiatives (Business Wire)
|
|
|
CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), the industry leader in branded cannabis products with a portfolio of America's most popular brands and the operator of Sunnyside dispensaries, today released its financial and operating results for the first quarter ended March 31, 2026. All financial information presented in this release is reported in accordance with U.S. GAAP and in U.S. dollars, unless otherwise indicated, and is available on the Company's investor website, here.
First Quarter 2026 Highlights
First quarter revenue of $151 million.
Gross profit of $75 million. Adjusted gross profit1 of $77 million; and an Adjusted gross margin1 of 50.7%.
SG&A of $54 million or 36.0% of revenue. Adjusted SG&A of $51 million or 33.7%.
Net loss of $17 million.
First quarter Adjusted EBITDA1 of $33 million and Adjusted EBITDA margin1 of 21.7%.
Retained the No. 1 share position in multiple billion dollar markets.2
Subsequent to Quarter ...
|
|
|
23.04.26 - 12:33
|
Cresco Labs to Report First Quarter 2026 Financial Results on May 8, 2026 (Business Wire)
|
|
|
CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “Company”), the industry leader in branded cannabis products with a portfolio of America's most popular brands and the operator of Sunnyside dispensaries, today announced it will report financial results for the quarter ended March 31st, 2026 on Friday, May 8, 2026 before the market opens.
The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights.
Event: Cresco Labs First Quarter 2026 Earnings Conference Call
Date: Friday, May 8, 2026
Time: 8:30 am ET
Webcast: LINK
Archived access to the webcast will be available for one year on the Cresco Labs investor relations website.
About Cresco Labs Inc.
Cresco Labs' mission is to normalize and professionalize the cannabis industry through a CPG approach to building national brands and a customer-focused retail experience, while acting as a steward for the industry on legislative and regula...
|
|
|
26.03.26 - 18:54
|
CANNABIS TEAMSTERS WIN STRIKE AT CRESCO LABS (PR Newswire)
|
|
|
Workers Secure Better Wages, Health Care, and Improved Working Conditions WYOMISSING, Pa., March 26, 2026 /PRNewswire/ -- After 20 days on strike, Teamsters Local 429 members at Sunnyside Dispensary have secured a new contract. Sunnyside is a subsidiary of Cresco Labs, a publicly traded......
|
|
|
|
|
|
|
05.03.26 - 12:33
|
Cresco Labs Delivers Q4 2025 Revenue of $162 Million and Sequential Margin Improvement (Business Wire)
|
|
|
CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), the industry leader in branded cannabis products with a portfolio of America's most popular brands and the operator of Sunnyside dispensaries, today released its financial and operating results for the fourth quarter ended and year ended December 31, 2025. All financial information presented in this release is reported in accordance with U.S. GAAP and in U.S. dollars, unless otherwise indicated, and is available on the Company's investor website, here.
Fiscal Year 2025 Highlights
Revenue of $656 million. Operating cash flow of $73 million and Free Cash Flow1 of $38 million.
Gross profit of $325 million. Adjusted gross profit1 of $329 million; and an Adjusted gross margin1 of 50.2%.
SG&A of $218 million. Reduced Adjusted SG&A1 by 5.7% year-over-year to $200 million, or 30.4%.
Net loss of $140 million, which includes one-time, non-cash charges of $105 million related to the Company's i...
|
|
|
26.02.26 - 22:06
|
CANNABIS TEAMSTERS AT CRESCO LABS GO ON STRIKE (PR Newswire)
|
|
|
Workers Demand Fair Wages, Stable Hours, and Respect WYOMISSING, Pa., Feb. 26, 2026 /PRNewswire/ -- Teamsters at the Sunnyside dispensary in Wyomissing, Pennsylvania voted unanimously to authorize a strike after the company failed to present a contract that fairly compensates its workers.......
|
|
|
23.02.26 - 12:31
|
Cresco Labs to Report Fourth Quarter 2025 Financial Results on March 5, 2026 (Business Wire)
|
|
|
CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “Company”), the industry leader in branded cannabis products with a portfolio of America's most popular brands and the operator of Sunnyside dispensaries, today announced it will report financial results for the full year and quarter ended December 31st, 2025 on Thursday, March 5, 2026 before the market opens.
The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights.
Event: Cresco Labs Fourth Quarter 2025 Earnings Conference Call
Date: Thursday, March 5, 2026
Time: 8:30 am ET
Webcast: LINKConference Call Registration: LINKDial-in: 1-833-470-1428 (US Toll Free), 1-646-844-6383 (US Local)
Access Code: 152399
Archived access to the webcast will be available for one year on the Cresco Labs investor relations website.
About Cresco Labs Inc.
Cresco Labs' mission is to normalize and professionalize the cannabis industry through a CPG ap...
|
|
|
|
|
|
|
|
|
|
|
05.11.25 - 12:33
|
Cresco Labs Delivers Strong Q3, Maintains Market Leadership, and Unlocks New Growth Opportunities (Business Wire)
|
|
|
CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), the industry leader in branded cannabis products with a portfolio of America's most popular brands and the operator of Sunnyside dispensaries, today released its financial and operating results for the third quarter ended September 30, 2025. All financial information presented in this release is reported in accordance with U.S. GAAP and in U.S. dollars, unless otherwise indicated, and is available on the Company's investor website, here.
Third Quarter 2025 Highlights
Third quarter revenue of $165 million. Third quarter operating cash flow of $6 million.
Gross profit of $79 million. Adjusted gross profit1 of $80 million; and an Adjusted gross margin1 of 48.8%.
SG&A of $52 million or 31.3% of revenue.
Net loss of $22 million, includes a $16 million loss for debt extinguishment related to the refinancing of the Company's senior secured term loan, and non-cash impairment charges of $2 mi...
|
|
|
|
|
22.10.25 - 12:36
|
Cresco Labs to Report Third Quarter 2025 Financial Results on November 5, 2025 (Business Wire)
|
|
|
CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “Company”), the industry leader in branded cannabis products with a portfolio of America's most popular brands and the operator of Sunnyside dispensaries, today announced it will report financial results for the third quarter ended September 30th, 2025 on Wednesday, November 5, 2025 before the market opens.
The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights.
Event: Cresco Labs Third Quarter 2025 Earnings Conference Call
Date: Wednesday, November 5, 2025
Time: 8:30 am ET
Webcast: LINKConference Call Registration: LINKDial-in: 1-833-470-1428 (US Toll Free), 1-646-844-6383 (US Local)
Access Code: 307245
Archived access to the webcast will be available for one year on the Cresco Labs investor relations website.
About Cresco Labs Inc.
Cresco Labs' mission is to normalize and professionalize the cannabis industry through a CPG ap...
|
|
|
29.09.25 - 17:18
|
CSE Bulletin: MOC Eligibility Update (Newsfile)
|
|
|
Toronto, Ontario--(Newsfile Corp. - September 29, 2025) - The following CSE-Listed symbol will become MOC Eligible as detailed below. Symbol Company Name Effective Date CL Cresco Labs Inc. - Subor......
|
|
|
17.09.25 - 01:54
|
Cresco Labs Announces Voting Results of Its Annual General and Special Meeting of Shareholders (Business Wire)
|
|
|
CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), today announced the results of its annual general and special meeting of shareholders (the “Meeting”) held on September 16, 2025.
At the Meeting, the number of directors of the Company for the ensuing year was fixed at seven (7) and the following nominees for election as directors of the Company were elected by a majority of votes cast by the shareholders virtually present or represented by proxy at the Meeting:
Charles Bachtell
Gerald F. Corcoran
Robert M. Sampson
Thomas J. Manning
Marc Lustig
Michele Roberts
Randy D. Podolsky
In addition, Baker Tilly US, LLP was appointed as the Company's auditor for the ensuing year.
Shareholders also voted to approve the Company's Award Exchange Program (the “Award Exchange”). Under the Award Exchange, certain employees were given the option to exchange certain underwater options for a like number of full value awards with new three-year...
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
